The Multiple Faces of Valosin-Containing Protein-Associated Diseases: Inclusion Body Myopathy with Paget’s Disease of Bone, Frontotemporal Dementia, and Amyotrophic Lateral Sclerosis (original) (raw)
Acharyya S et al (2007) Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 117:889–901 ArticlePubMedCAS Google Scholar
Alexandru G et al (2008) UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. Cell 134:804–816 ArticlePubMedCAS Google Scholar
Alonso A et al (2009) Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Eur J Neurol 16:745–751 ArticlePubMedCAS Google Scholar
Arnold SE et al (2000) Quantitative neurohistological features of frontotemporal degeneration. Neurobiol Aging 21:913–919 ArticlePubMedCAS Google Scholar
Badadani M et al (2010) VCP associated inclusion body myopathy and Paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. PLoS One 5:1–15 Article Google Scholar
Bersano A et al (2009) Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation. Neurobiol Aging 30:752–758 ArticlePubMedCAS Google Scholar
Bhatnagar S, Kumar A (2010) Therapeutic targeting of signaling pathways in muscular dystrophy. J Mol Med 88:155–166 ArticlePubMedCAS Google Scholar
Cairns NJ et al (2007) TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 171:227–240 ArticlePubMedCAS Google Scholar
Chang YC et al (2011) Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model. PLoS Genet 7:e1001288 ArticlePubMedCAS Google Scholar
Confalonieri F, Duguet M (1995) A 200-amino acid ATPase module in search of a basic function. Bioessays 17:639–650 ArticlePubMedCAS Google Scholar
Crippa V et al (2010a) A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases. Autophagy 6:958–960 ArticlePubMed Google Scholar
Crippa V et al (2010b) The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum Mol Genet 19:3440–3456 ArticlePubMedCAS Google Scholar
Custer SK et al (2010) Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum Mol Genet 19:1741–1755 ArticlePubMedCAS Google Scholar
Dai RM et al (1998) Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin–proteasome-mediated degradation of IkappaBalpha. J Biol Chem 273:3562–3573 ArticlePubMedCAS Google Scholar
Dai RM, Li CC (2001) Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat Cell Biol 3:740–744 ArticlePubMedCAS Google Scholar
Daroszewska A, Ralston SH (2006) Mechanisms of disease: genetics of Paget's disease of bone and related disorders. Nat Clin Pract Rheumatol 2:270–277 ArticlePubMedCAS Google Scholar
DeLaBarre B et al (2006) Central pore residues mediate the p97/VCP activity required for ERAD. Mol Cell 22:451–462 ArticlePubMedCAS Google Scholar
Djamshidian A et al (2009) A novel mutation in the VCP gene (G157R) in a German family with inclusion-body myopathy with Paget disease of bone and frontotemporal dementia. Muscle Nerve 39:389–391 ArticlePubMedCAS Google Scholar
Fanganiello RD et al (2011) A Brazilian family with hereditary inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Braz J Med Biol Res 44:374–380 ArticlePubMedCAS Google Scholar
Farpour F et al (2011) Radiological features of Paget disease of bone associated with VCP myopathy. PMID: 21643886
Fernandez-Saiz V, Buchberger A (2010) Imbalances in p97 co-factor interactions in human proteinopathy. EMBO Rep 11:479–485 ArticlePubMedCAS Google Scholar
Gidaro T et al (2008) An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene. Muscle Nerve 37:111–114 ArticlePubMed Google Scholar
Graham KM et al (2010) Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-kappaB pathway. J Neurol Sci 294:43–50 ArticlePubMedCAS Google Scholar
Guyant-Marechal L et al (2006) Valosin-containing protein gene mutations: clinical and neuropathologic features. Neurology 67:644–651 ArticlePubMedCAS Google Scholar
Haslbeck KM et al (2005) The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy. Acta Neuropathol 110:247–254 ArticlePubMedCAS Google Scholar
Haubenberger D et al (2005) Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene. Neurology 65:1304–1305 ArticlePubMedCAS Google Scholar
Hubbers CU et al (2007) Pathological consequences of VCP mutations on human striated muscle. Brain 130:381–393 ArticlePubMed Google Scholar
Janiesch PC et al (2007) The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy. Nat Cell Biol 9:379–390 ArticlePubMedCAS Google Scholar
Jarosch E et al (2002) Protein dislocation from the endoplasmic reticulum—pulling out the suspect. Traffic 3:530–536 ArticlePubMedCAS Google Scholar
Johnson JO et al (2010) Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68:857–864 ArticlePubMedCAS Google Scholar
Ju JS, Weihl CC (2010) Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy. Hum Mol Genet 19:R38–R45 ArticlePubMedCAS Google Scholar
Kakizuka A (2008) Roles of VCP in human neurodegenerative disorders. Biochem Soc Trans 36:105–108 ArticlePubMedCAS Google Scholar
Kaleem M et al (2007) Identification of a novel valosin-containing protein polymorphism in late-onset Alzheimer's disease. Neurodegener Dis 4:376–381 ArticlePubMedCAS Google Scholar
Kim EJ, Park YE, Kim DS et al (2011) Inclusion body myopathy with Paget disease of bone and frontotemporal dementia linked to VCP p.Arg155Cys in a Korean family. Arch Neurol 68:787–796 ArticlePubMed Google Scholar
Kimonis VE et al (2008a) VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim Biophys Acta 1782:744–748 PubMedCAS Google Scholar
Kimonis VE et al (2000) Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone. Genet Med 2:232–241 ArticlePubMedCAS Google Scholar
Kimonis VE et al (2008b) Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am J Med Genet A 146A:745–757 ArticlePubMed Google Scholar
Korolchuk VI et al (2009) Autophagy inhibition compromises degradation of ubiquitin–proteasome pathway substrates. Mol Cell 33:517–527 ArticlePubMedCAS Google Scholar
Kovach MJ et al (2001) Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol Genet Metab 74:458–475 ArticlePubMedCAS Google Scholar
Krause S et al (2007) Brain imaging and neuropsychology in late-onset dementia due to a novel mutation (R93C) of valosin-containing protein. Clin Neuropathol. 26:232–240 PubMedCAS Google Scholar
Kumar KR et al (2010) Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findings. Neuromuscul Disord 20:330–334 ArticlePubMed Google Scholar
Kwiatkowski TJ Jr et al (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205–1208 ArticlePubMedCAS Google Scholar
Lagier-Tourenne C et al (2010) TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19:R46–R64 ArticlePubMedCAS Google Scholar
Leigh PN, Wijesekera LC (2010) Motor neuron disease: focusing the mind on ALS: updated practice parameters. Nat Rev Neurol 6:191–192 ArticlePubMed Google Scholar
Leyton CE, Hodges JR (2010) Frontotemporal dementias: recent advances and current controversies. Ann Indian Acad Neurol 13:S74–S80 PubMed Google Scholar
Ling SC et al (2010) ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci U S A 107:13318–13323 ArticlePubMedCAS Google Scholar
Logroscino G et al (2008) Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 79:6–11 ArticlePubMedCAS Google Scholar
Lomen-Hoerth C et al (2003) Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60:1094–1097 PubMedCAS Google Scholar
McGuire V et al (1996) Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 47:571–573 PubMedCAS Google Scholar
Meyer HH et al (2000) A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways. EMBO J 19:2181–2192 ArticlePubMedCAS Google Scholar
Miller TD et al (2009) Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD): clinical features including sphincter disturbance in a large pedigree. J Neurol Neurosurg Psychiatry 80:583–584 ArticlePubMedCAS Google Scholar
Mizushima N et al (2004) In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 15:1101–1111 ArticlePubMedCAS Google Scholar
Muller JM et al (2007) Targeted deletion of p97 (VCP/CDC48) in mouse results in early embryonic lethality. Biochem Biophys Res Commun 354:459–465 ArticlePubMedCAS Google Scholar
Neary D et al (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546–1554 PubMedCAS Google Scholar
Pasquali L et al (2010) The role of autophagy: what can be learned from the genetic forms of amyotrophic lateral sclerosis. CNS Neurol Disord Drug Targets 9:268–278 PubMedCAS Google Scholar
Rabinovich E et al (2002) AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol Cell Biol 22:626–634 ArticlePubMedCAS Google Scholar
Rabouille C et al (1998) Syntaxin 5 is a common component of the NSF- and p97-mediated reassembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro. Cell 92:603–610 ArticlePubMedCAS Google Scholar
Rape M et al (2001) Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell 107:667–677 ArticlePubMedCAS Google Scholar
Reid IR et al (2005) Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Engl J Med 353:898–908 ArticlePubMedCAS Google Scholar
Ritson GP et al (2010) TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J Neurosci 30:7729–7739 ArticlePubMedCAS Google Scholar
Roberson ED (2011) Contemporary approaches to Alzheimer's disease and frontotemporal dementia. Methods Mol Biol 670:1–9 ArticlePubMed Google Scholar
Rohrer JD, Warren JD, Reiman D et al (2011) A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes. J Neurol 258:1494–1496 ArticlePubMed Google Scholar
Rusten TE, Filimonenko M, Rodahl LM et al (2008) ESCRTing autophagic clearance of aggregating proteins. Autophagy 4:233–236 CAS Google Scholar
Schroder R et al (2005) Mutant valosin-containing protein causes a novel type of frontotemporal dementia. Ann Neurol 57:457–461 ArticlePubMed Google Scholar
Shaw CE (2010) Capturing VCP: another molecular piece in the ALS jigsaw puzzle. Neuron 68:812–814 ArticlePubMedCAS Google Scholar
Siciliano G et al (2010) Clinical trials for neuroprotection in ALS. CNS Neurol Disord Drug Targets 9:305–313 PubMedCAS Google Scholar
Siris E et al (1996) Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. J Clin Endocrinol Metab 81:961–967 ArticlePubMedCAS Google Scholar
Spina et al (2008) Frontotemporal dementia associated with a valosin-containing protein mutation: report of three families. The FASEB Journal 22:58.4 (Abstract)
Sreedharan J et al (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:1668–1672 ArticlePubMedCAS Google Scholar
Stojkovic T et al (2009) Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget's disease of bone and frontotemporal dementia. Neuromuscul Disord 19:316–323 ArticlePubMed Google Scholar
Strong MJ et al (2003) Cognitive impairment, frontotemporal dementia, and the motor neuron diseases. Ann Neurol 54(Suppl 5):S20–S23 ArticlePubMed Google Scholar
Traynor BJ et al (1999) Incidence and prevalence of ALS in Ireland, 1995–1997: a population-based study. Neurology 52:504–509 PubMedCAS Google Scholar
Turner RS et al (1996) Clinical, neuroimaging, and pathologic features of progressive nonfluent aphasia. Ann Neurol 39:166–173 ArticlePubMedCAS Google Scholar
van der Zee J et al (2009) Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His. Neurology 73:626–632 ArticlePubMed Google Scholar
Vance C et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323:1208–1211 ArticlePubMedCAS Google Scholar
Vesa J et al (2009) Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts. Neuromuscul Disord 19:766–772 ArticlePubMed Google Scholar
Wang Q et al (2004) Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions. J Struct Biol 146:44–57 ArticlePubMedCAS Google Scholar
Watts GD et al (2003) Clinical and genetic heterogeneity in chromosome 9p associated hereditary inclusion body myopathy: exclusion of GNE and three other candidate genes. Neuromuscul Disord 13:559–567 ArticlePubMed Google Scholar
Watts GD et al (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36:377–381 ArticlePubMedCAS Google Scholar
Watts GD et al (2007) Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Clin Genet 72:420–426 ArticlePubMedCAS Google Scholar
Weihl CC et al (2006) Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum Mol Genet 15:189–199 ArticlePubMedCAS Google Scholar
Weihl CC et al (2007) Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. Hum Mol Genet 16:919–928 ArticlePubMedCAS Google Scholar
Weihl CC et al (2009) Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia. Neuromuscul Disord 19:308–315 ArticlePubMed Google Scholar
Wong E, Cuervo AM (2010) Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 13:805–811 ArticlePubMedCAS Google Scholar
Ye Y et al (2001) The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 414:652–656 ArticlePubMedCAS Google Scholar
Zhukareva V et al (2001) Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol 49:165–175 ArticlePubMedCAS Google Scholar